Nitrous oxide oral - Hillhurst Biopharmaceuticals
Alternative Names: HBI-201Latest Information Update: 04 Jan 2024
At a glance
- Originator Hillhurst Biopharmaceuticals
- Class Analgesics; Nitrogen compounds; Nitrogen oxides; Small molecules
- Mechanism of Action Guanylate cyclase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Acute pain